Bone Therapeutics's total assets for Q4 2025 were €3.42M, a decrease of -27.96% from the previous quarter. DE:BT1 total liabilities were €5.37M for the fiscal quarter, a -82.97% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.